"Entrepreneurial State" June 2011-15, transmitted by venture capital State (cyzone.CN) and the Suzhou Industrial Park jointly organise a large innovation of enterprise science and Technology Development Council exhibition “ innovate China 2011” match in view of Jinling Garden International Hotel Suzhou Guan Yuan Chamber. Innovation China 2011 commercial seven major areas of concern, ranging from mobile Internet, wireless terminal all investment opportunities. Suzhou-game from the Internet, health, energy, high-tech 19 enterprises in areas such as the stage show their products, technologies and business models, and face-to-face communication and exchange with onsite participant.
figure for Suzhou Industrial Park for biomedical technology limited Source: venture bang
Following is the text record:
Corporate presentation:
For really biological: I to members describes about we company of some situation, we company is Suzhou for really biological medicine technology limited, currently we main do of direction is a new of industry, we main is to technology for driven of a enterprise, we now is Jiangsu Province tumor molecular diagnosis Center, is national focus laboratory, we is 2008 point get in the new of investment, we now has 62 a people, we has a workshop 2,400 square, under construction of 1500 square of laboratory, here we has 2 item Fund project.
And mainland of company not as of, we diagnosis is from effect learn, pathological learn, to serum protein immune group of, molecular level, molecular level has in tumor aspects application many, but has been no application in clinical aspects, we in this aspects do has some technology method, simple to members describes about, this is tumor molecular diagnosis of a market situation, entire molecular diagnosis market actually started is 90 generation, in China has has a new of molecular diagnosis market, and is infectious diseases of diagnosis market, has two a company. We complement each other very well, but his lack of technology and products, this market has a typical applicability of technology market. We are faced with an opportunity, is an industrial upgrading. I to members simple describes about, tumor clinical diagnosis need solution of core problem, then then simple describes about we of products of market situation, in tumor diagnosis this aspects, actually tumor for decades years to and no large of growth, mortality still increased, from pharmaceutical, also is is difficult to solution of, so early sieve check tumor, is most important of core problem, second a is if he has has diagnosis, we how to do accurate diagnosis, we how shaped benign, and malignant organization identification, also has a is personalized treatment, now not as has, in treatment zhiqian we first to detection about, see what is how back thing, we in this aspects of review also comparison more, fifth a is operation Hou recurrence monitoring.
Details of the product is a product of what we are doing, the technology is the brand of technology, we are now able to achieve several aspects of tumor molecular diagnosis, the first area is the high risk population screening, technology with our content we made with lean detection markets do not like. We monitor with lots of recurrent is the first, a $ 200 million has been used. This is our technology platform, although many of our products. We a began do of not single products, we do of is technology platform, we has a new of technology platform, MID, this is we own of platform, single of technology not I of, I to he integration in together, we has three a molecular table, this is I just began investment of when, this molecular table is 80 years to only entered clinical experimental stage of molecular marked. Behind is we has several technology, we has series of technology do some detection, this is we do of a clinical work, March has completed has, total has two a card, this is first a can do plasma detection, this is we currently of market situation, I simple said about clinical certification work, we has 7 a card, this is we market of policy, in Shanghai, and Guangzhou, and Beijing, and area are has breakthrough.
